Monday, May 15, 2017 - 6:00PM CEST (Central European Summer Time)
Cancer immunotherapy is emerging as one of the most promising areas of cancer research and treatment.Overall, the goal of cancer immunotherapy is to stimulate a patient's immune system to recognize cancer cells as foreign and attack them.
Tuesday, May 9, 2017 at 9:00PM EDT
This webinar will provide an updated overview of current standard therapies for stage III NSCLC. It will also review the most recent data and current trials likely to impact standards of care.
Wednesday, May 3, 2017,11:00AM EDT / 9:00AM MDT
This webinar will feature two presentations and will be followed by a question and answer session.
Wednesday, April 19, 2017 at 9:00PM EDT
In this program, we will cover: the incidence and epidemiology of brain metastases in NSCLC; its prognostic implications; current management, including surgical, radiation and systemic options.
Tuesday, March 21, 2017 at 9:00PM EST - Recording Available
With the integration of immunotherapy in the treatment of non-small cell lung cancer, recognition of potential side effects associated with immunotherapy and management of symptoms are essential components of overall care.
Thursday March 16, 2017 at 9:00PM EST - Recording Available
In this program we will examine the evolving therapeutic landscape for the treatment of squamous cell non-small cell lung cancer. The introduction of immune checkpoint inhibitors into treatment algorithms is the primary catalyst of new therapeutic options.
February 7, 2017 at 9:00PM EST - Recording Available
This presentation will provide an update on how immunotherapy has rapidly integrated into standard 1st and 2nd-Line and beyond treatment settings.
January 26, 2017 at 9:00PM EST - Recording Available
In this live webinar Dr. Taofeek K. Owonikoko and Dr. Ramaswamy Govindan will discuss key abstracts, presentations, and developments reported in Vienna, Austria during the recent (December 4-7, 2016) 17th World Conference on Lung Cancer (WCLC).
December 20, 2016 at 9:00PM EST - Recording Available
Immunotherapy is now a standard option for treatment of patients with non-small cell lung cancer and has been shown to improve survival compared to chemotherapy in a subset of patients. This
November 16, 2016 at 9:00PM EST - Recording Available
Recent meetings of the European Society of Medical Oncology (October 7-11, 2016) and the IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology (September 22-24, 2016) provided important updates and new information relative to the multidisciplinary management of patients with lung cancer.